Edgewise Therapeutics to Participate in Upcoming Investor Conferences
Edgewise Therapeutics announced that management will participate in two investor conferences: the Guggenheim Healthcare Innovation Conference on November 10, 2026, and the Truist Biopharma Symposium on November 12, 2026. Webcasts will be available on the company’s Events & Presentations page and for replay for a limited time.
Why it matters — EWTX watchers can follow management’s conference remarks through the scheduled webcasts and limited-time replays.